ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1801

An Engineered Extracellular Matrix‐rich Decellularized Substrate Based Podocytes Culture System to Study Intracellular Complement Production and Activation

Abhigyan Satyam1, Maria Tsokos2 and George Tsokos2, 1Division of Rheumatology & Clinical Immunology/Beth Israel Deaconess Medical Center/Harvard Medical School, boston, 2Division of Rheumatology & Clinical Immunology/Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2020

Keywords: complement, hypoxia, Lupus nephritis, Tissue Engineering

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Current technologies do not support long-term cell viability, differentiation and maintenance of podocytes. We developed a biophysical approach, termed macromolecular crowding (MMC), to create extracellular matrix (ECM)-rich tissue equivalents and decellularization. This approach generates decellularized grafts that scaffold podocytes to grow in an environment similar to native conditions. To show a potential application of this newly designed culture system we studied complement (C) activation in podocytes exposed to IgG from individuals with lupus nephritis (LN) and hypoxia.

Methods: Human skin fibroblasts were cultured under MMC and then decellularized. Human immortalized podocytes were cultured on the decellularized matrix (DCM) at 33°C for 7 days and at 37°C for 14 days (https://doi.org/10.1002/adfm.201908752). ECM deposition in the DCM-coated dishes was analyzed by SDS-PAGE, immunofluorescence (IF) and atomic force microscopy and expression of podocyte markers by western blotting (WB) and IF. Podocytes were then exposed to IgG from patients with LN or Dimethyloxalylglycine (DMOG) and C activation was studied (WB and IF).

Results: We found that DCM-coated dishes contained all major ECM molecules (laminin, fibronectin, collagen I and IV) and podocytes survived and differentiated on DCM-coated plates significantly better than on non-coated plates, as shown by the development of interdigitating foot process and increased expression of nephrin and synaptopodin (fig. 1). Podocytes exposed to LN IgG (fig. 2) or DMOG (fig. 3) displayed increased levels of complement molecules (C3, C4, C5, C5b9) and C3 activation products.

Conclusion: Engineering in vitro microenvironment with decellularized matrix enhances podocyte viability, native physiology and morphology. This novel system enabled us to demonstrate increased complement factor production by podocytes exposed to LN IgG or hypoxia and intracellular complement activation.

(a) Atomic Force Microscopy (AFM) shows better podocyte morphology with interdigitating foot processes on DCM-coated dishes. (b) Immunofluorescence shows enhanced expression and co-localization of actin and synaptopodin on DCM-coated dishes. Western blotting (c) (densitometric readings d,) confirmed higher expression of nephrin and synaptopodin on decellularized ECM rich substrate.

Lupus IgG enhances production of activated C3 molecules. Lupus IgG (L IgG), Normal IgG (N IgG).

(b) DMOG enhances production of activated C3 molecules.Exposure of podocytes to DMOG (a) upregulates expression of HIF-1α and (b) enhances production of C3 split products. Western blotting analysis of activated C3 using a pan-C3 antibody that detects activated C3 split molecules.


Disclosure: A. Satyam, None; M. Tsokos, None; G. Tsokos, None.

To cite this abstract in AMA style:

Satyam A, Tsokos M, Tsokos G. An Engineered Extracellular Matrix‐rich Decellularized Substrate Based Podocytes Culture System to Study Intracellular Complement Production and Activation [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/an-engineered-extracellular-matrix%e2%80%90rich-decellularized-substrate-based-podocytes-culture-system-to-study-intracellular-complement-production-and-activation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-engineered-extracellular-matrix%e2%80%90rich-decellularized-substrate-based-podocytes-culture-system-to-study-intracellular-complement-production-and-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology